Prior infection by a parasitic hookworm has been shown to protect mice from severe SARS-CoV-2 disease, offering a potential explanation as to why certain human populations seemed to fare better during ...

Two major new reports have identified some of the reasons why certain populations fared better while others were hit hard by the COVID-19 pandemic, which was caused by the SARS-CoV-2 virus. In one ...

Researchers at the George Washington University School of Medicine and Health Sciences in partnership with Baylor College of Medicine report encouraging results from a phase 2 clinical trial ...

Emodepside, an antiparasitic drug registered for veterinary use, is being studied for human Trichuris trichiura and hookworm infections. New research findings are summarized in a short video.

Expelled worms which were key to the study. Scientists treated the population with worming tablets, collected their faeces then sieved it to collect worms. This enabled the research team to to plot ...

A phase 2 human clinical trial of an antigen for a parasitic infection caused by hookworms has been shown to be effective in limiting the intensity of infection, paving the way for the development of ...